vs
Side-by-side financial comparison of JFrog Ltd (FROG) and HUTCHMED (China) Ltd (HCM). Click either name above to swap in a different company.
HUTCHMED (China) Ltd is the larger business by last-quarter revenue ($270.8M vs $145.3M, roughly 1.9× JFrog Ltd). HUTCHMED (China) Ltd runs the higher net margin — 0.7% vs -10.5%, a 11.2% gap on every dollar of revenue. On growth, JFrog Ltd posted the faster year-over-year revenue change (25.2% vs -16.5%). JFrog Ltd produced more free cash flow last quarter ($49.9M vs $3.4M).
JFrog Ltd is a global DevOps technology provider that delivers end-to-end software release, artifact management, and security solutions. It serves clients across tech, finance, retail, and manufacturing sectors, helping teams streamline development and delivery workflows for cloud, on-premises, and hybrid infrastructure.
HUTCHMED (China) LtdHCMEarnings & Financial Report
HUTCHMED (China) Ltd is a biopharmaceutical firm focused on discovering, developing and commercializing targeted and immunotherapies for oncology and immunological diseases. It operates across China and global markets, with multiple marketed oncology drugs and a robust pipeline of late-stage clinical candidates addressing unmet patient needs.
FROG vs HCM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $145.3M | $270.8M |
| Net Profit | $-15.2M | $2.0M |
| Gross Margin | 77.9% | 37.7% |
| Operating Margin | -14.7% | -13.2% |
| Net Margin | -10.5% | 0.7% |
| Revenue YoY | 25.2% | -16.5% |
| Net Profit YoY | 34.4% | -83.6% |
| EPS (diluted) | $-0.13 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $145.3M | $270.8M | ||
| Q3 25 | $136.9M | — | ||
| Q2 25 | $127.2M | $277.7M | ||
| Q1 25 | $122.4M | $324.5M | ||
| Q4 24 | $116.1M | — | ||
| Q3 24 | $109.1M | — | ||
| Q2 24 | $103.0M | $305.7M | ||
| Q1 24 | $100.3M | — |
| Q4 25 | $-15.2M | $2.0M | ||
| Q3 25 | $-16.4M | — | ||
| Q2 25 | $-21.7M | $455.0M | ||
| Q1 25 | $-18.5M | $11.9M | ||
| Q4 24 | $-23.2M | — | ||
| Q3 24 | $-22.9M | — | ||
| Q2 24 | $-14.3M | $25.8M | ||
| Q1 24 | $-8.8M | — |
| Q4 25 | 77.9% | 37.7% | ||
| Q3 25 | 77.4% | — | ||
| Q2 25 | 76.3% | 0.1% | ||
| Q1 25 | 75.3% | 48.0% | ||
| Q4 24 | 75.4% | — | ||
| Q3 24 | 75.0% | — | ||
| Q2 24 | 78.8% | 41.1% | ||
| Q1 24 | 79.5% | — |
| Q4 25 | -14.7% | -13.2% | ||
| Q3 25 | -15.8% | — | ||
| Q2 25 | -20.4% | -1.3% | ||
| Q1 25 | -18.8% | -5.0% | ||
| Q4 24 | -21.9% | — | ||
| Q3 24 | -27.4% | — | ||
| Q2 24 | -18.6% | -9.0% | ||
| Q1 24 | -16.6% | — |
| Q4 25 | -10.5% | 0.7% | ||
| Q3 25 | -12.0% | — | ||
| Q2 25 | -17.0% | 163.8% | ||
| Q1 25 | -15.1% | 3.7% | ||
| Q4 24 | -20.0% | — | ||
| Q3 24 | -21.0% | — | ||
| Q2 24 | -13.9% | 8.4% | ||
| Q1 24 | -8.8% | — |
| Q4 25 | $-0.13 | $0.00 | ||
| Q3 25 | $-0.14 | — | ||
| Q2 25 | $-0.19 | $0.52 | ||
| Q1 25 | $-0.16 | $0.01 | ||
| Q4 24 | $-0.21 | — | ||
| Q3 24 | $-0.21 | — | ||
| Q2 24 | $-0.13 | $0.03 | ||
| Q1 24 | $-0.08 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $704.4M | $1.4B |
| Total DebtLower is stronger | — | $93.2M |
| Stockholders' EquityBook value | $887.4M | $1.2B |
| Total Assets | $1.3B | $1.8B |
| Debt / EquityLower = less leverage | — | 0.08× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $704.4M | $1.4B | ||
| Q3 25 | $651.1M | — | ||
| Q2 25 | $611.7M | $1.4B | ||
| Q1 25 | $563.5M | $836.1M | ||
| Q4 24 | $522.0M | — | ||
| Q3 24 | $467.8M | — | ||
| Q2 24 | $591.3M | $802.5M | ||
| Q1 24 | $579.6M | — |
| Q4 25 | — | $93.2M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $93.4M | ||
| Q1 25 | — | $82.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $82.1M | ||
| Q1 24 | — | — |
| Q4 25 | $887.4M | $1.2B | ||
| Q3 25 | $859.4M | — | ||
| Q2 25 | $826.5M | $1.2B | ||
| Q1 25 | $800.0M | $759.9M | ||
| Q4 24 | $773.5M | — | ||
| Q3 24 | $756.2M | — | ||
| Q2 24 | $721.4M | $740.1M | ||
| Q1 24 | $707.8M | — |
| Q4 25 | $1.3B | $1.8B | ||
| Q3 25 | $1.3B | — | ||
| Q2 25 | $1.2B | $1.8B | ||
| Q1 25 | $1.2B | $1.3B | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.0B | $1.3B | ||
| Q1 24 | $997.1M | — |
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.08× | ||
| Q1 25 | — | 0.11× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.11× | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $50.7M | $8.2M |
| Free Cash FlowOCF − Capex | $49.9M | $3.4M |
| FCF MarginFCF / Revenue | 34.3% | 1.2% |
| Capex IntensityCapex / Revenue | 0.6% | 1.8% |
| Cash ConversionOCF / Net Profit | — | 4.21× |
| TTM Free Cash FlowTrailing 4 quarters | $142.3M | $-96.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $50.7M | $8.2M | ||
| Q3 25 | $30.2M | — | ||
| Q2 25 | $36.1M | $-72.9M | ||
| Q1 25 | $28.8M | $40.3M | ||
| Q4 24 | $49.1M | — | ||
| Q3 24 | $27.6M | — | ||
| Q2 24 | $16.7M | $-39.8M | ||
| Q1 24 | $17.5M | — |
| Q4 25 | $49.9M | $3.4M | ||
| Q3 25 | $28.8M | — | ||
| Q2 25 | $35.5M | $-82.2M | ||
| Q1 25 | $28.1M | $32.5M | ||
| Q4 24 | $48.5M | — | ||
| Q3 24 | $26.7M | — | ||
| Q2 24 | $16.0M | $-49.9M | ||
| Q1 24 | $16.6M | — |
| Q4 25 | 34.3% | 1.2% | ||
| Q3 25 | 21.0% | — | ||
| Q2 25 | 27.9% | -29.6% | ||
| Q1 25 | 23.0% | 10.0% | ||
| Q4 24 | 41.8% | — | ||
| Q3 24 | 24.5% | — | ||
| Q2 24 | 15.5% | -16.3% | ||
| Q1 24 | 16.6% | — |
| Q4 25 | 0.6% | 1.8% | ||
| Q3 25 | 1.0% | — | ||
| Q2 25 | 0.5% | 3.3% | ||
| Q1 25 | 0.5% | 2.4% | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 0.9% | — | ||
| Q2 24 | 0.7% | 3.3% | ||
| Q1 24 | 0.8% | — |
| Q4 25 | — | 4.21× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -0.16× | ||
| Q1 25 | — | 3.38× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -1.54× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
